Augmentation of transforming growth factor-β signaling for the treatment of neurological disorders is a research paper published in Neural Regeneration Research (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NINDS NIH HHS
Grant: R01 NS092868
NIA NIH HHS
Grant: RF1 AG059694
National Institutes of Health
Grant: 1R01NS092868-01A1
TGF-β Signaling as a Novel Therapeutic Target for Mild Traumatic Brain Injury
National Institutes of Health
Grant: 1RF1AG059694-01
Targeting Cerebrovascular TGF Signaling in Alzheimer's Disease
FWCI
0.55
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals